Generic cancer drug put to the test
NCT ID NCT07492173
First seen Mar 28, 2026 · Last updated Apr 22, 2026 · Updated 2 times
Summary
This study tested whether a new generic version of a cancer drug is absorbed by the body the same way as the existing brand-name drug. It involved 76 adults with solid tumors who took the drugs while fasting and after eating. The goal was to see if the two drug versions work similarly in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hunan Cancer Hospital
Changsha, Hunan, China
Conditions
Explore the condition pages connected to this study.